Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FFR<sub>CT</sub> Analysis Rejections: Comparison of Frequency and Associated Factors Between Two CT Scanners.

AJR. American journal of roentgenology·2026
Same author

Tau20-RETROmapping System Identifies Driver-Like Activation Patterns in Real-Time During Persistent Atrial Fibrillation.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Radiomics for the Detection and Prediction of Cancer Therapy-Related Cardiotoxicity.

JACC. Advances·2026
Same author

Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Combined emission ratiometry and motion tracking for optical mapping of contracting hearts: Validation with monophasic action potentials.

The Journal of physiology·2026
Same author

Mechanistic interpretations of sustained ventricular fibrillation: The role of mapping methodology, model and time.

Heart international·2026

Related Experiment Video

Updated: Jul 4, 2026

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta-Analysis of Randomized Trials.

Harroop Bola1,2, Aksaan Arif1, Joshua J Hon1

  • 1Faculty of Medicine, Imperial College London, England, London, UK.

Pacing and Clinical Electrophysiology : PACE
|July 3, 2026
PubMed
Summary

Cryoballoon ablation (CBA) and radiofrequency ablation (RFA) show similar effectiveness for persistent atrial fibrillation (PeAF) at 12 months. CBA significantly reduces procedure time without increasing major complications, offering a more efficient treatment option.

Keywords:
catheter ablationcryoballoon ablationpersistent atrial fibrillationradiofrequency ablation

More Related Videos

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
11:03

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Experiment Videos

Last Updated: Jul 4, 2026

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
11:03

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Technology

Background:

  • Persistent atrial fibrillation (PeAF) management often requires pulmonary vein isolation (PVI).
  • Cryoballoon ablation (CBA) presents a streamlined alternative to radiofrequency ablation (RFA).
  • Comparative efficacy and efficiency of CBA versus RFA in PeAF remain under investigation.

Purpose of the Study:

  • To compare the clinical efficacy, procedural efficiency, and safety of CBA and RFA for PeAF.
  • To conduct a meta-analysis of randomized controlled trials (RCTs) evaluating CBA versus RFA.
  • To assess long-term arrhythmia freedom and procedural outcomes.

Main Methods:

  • Systematic review of PubMed, Embase, and Scopus for relevant RCTs.
  • Inclusion of 5 RCTs with 1,091 patients (515 CBA, 576 RFA).
  • Analysis of 12-month freedom from atrial arrhythmia, atrial tachycardia/flutter, and repeat ablation rates; procedural time; and major complications.

Main Results:

  • CBA and RFA demonstrated equivalent 12-month freedom from any atrial arrhythmia (RR 0.97; p=0.71).
  • No significant difference in recurrence hazard (HR 0.91; p=0.56) or repeat ablation rates (RR 0.93; p=0.50).
  • CBA significantly reduced procedural time (MD -45.37 min; p<0.0001) with comparable major complication rates (1.5% vs 2.7%; p=0.18).

Conclusions:

  • CBA and RFA offer comparable 12-month arrhythmia-free survival and repeat ablation rates in PeAF patients.
  • CBA provides a significant procedural efficiency advantage over RFA.
  • Limitations include reliance on 12-month follow-up and variable rhythm surveillance protocols for assessing long-term durability.